• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session

    11/17/22 1:20:00 PM ET
    $ARDX
    $AUD
    $BBWI
    $BNOX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Broadcasting
    Consumer Discretionary
    Get the next $ARDX alert in real time by email

    Gainers

    • Elevate Credit, Inc. (NYSE:ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million.
    • Ardelyx Inc (NASDAQ:ARDX) shares jumped 45.1% to $1.7699 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.
    • Satixfy Communications Ltd. (NYSE:SATX) gained 37.3% to $36.14.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) surged 37.2% to $3.57.
    • CytomX Therapeutics, Inc. (NASDAQ:CTMX) jumped 24.8% to $1.5110 after the company and Regeneron announced a strategic research collaboration in the field of conditional bispecific therapeutics for the treatment of cancer.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) gained 23.5% to $7.29. Kiora Pharmaceuticals dosed first patient in ABACUS Phase 1b study evaluating KIO-301 for retinitis pigmentosa.
    • Nano Labs Ltd (NASDAQ:NA) surged 21.8% to $1.6444 following Q3 results.
    • LexinFintech Holdings Ltd. (NASDAQ:LX) jumped 20.3% to $1.8888. LexinFintech Holdings posted Q3 operating revenue of RMB2,690 million.
    • Cartesian Growth Corporation (NASDAQ:GLBL) shares gained 19.9% to $10.32 after dropping over 15% on Wednesday.
    • uCloudlink Group Inc. (NYSE:UCL) jumped 19.7% to $2.30. UCLOUDLINK regained Nasdaq compliance regarding minimum market value of publicly held shares.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) gained 18.2% to $3.2982. Zacks Small-Cap Research recently issued a note on the stock with a $24 valuation.
    • Bath & Body Works, Inc. (NYSE:BBWI) rose 18.1% to $36.77 after the company reported better-than-expected Q3 results and raised FY22 earnings forecast.
    • Atour Lifestyle Holdings Limited (NASDAQ:ATAT) gained 15% to $13.10.
    • Paltalk, Inc. (NASDAQ:PALT) jumped 14.7% to $1.71. The company recently posted strong Q3 sales.
    • Rail Vision Ltd. (NASDAQ:RVSN) gained 14.2% to $0.6849.
    • WaveDancer, Inc. (NASDAQ:WAVD) rose 13.2% to $0.8492.
    • Cuentas Inc. (NASDAQ:CUEN) rose 13.1% to $0.2828 after dropping 28% on Wednesday. Cuentas authorized a share repurchase program.
    • Macy's, Inc. (NYSE:M) gained 12.3% to $22.13 after the company reported better-than-expected Q3 EPS and sales results and raised FY22 EPS guidance.
    • RLX Technology Inc. (NYSE:RLX) gained 10.4% to $1.59 after the company reported Q3 financial results.
    • Fossil Group, Inc. (NASDAQ:FOSL) jumped 9.7% to $5.02. Fossil Group recently reported better-than-expected Q3 sales results.
    • Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) rose 5.8% to $0.6446. BML Investment Partners LP reported a 19.4% passive stake in Satsuma Pharmaceuticals as of November 14.
    • Cisco Systems, Inc. (NASDAQ:CSCO) rose 3.4% to $45.90 after the company reported better-than-expected Q1 results.

     

    Losers

    • Inotiv, Inc. (NASDAQ:NOTV) dropped 46.9% to $8.41. On November 16, Inotiv became aware U.S. Attorney's Office for Southern District of Florida criminally charged employees of supplier of non-human primates.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) shares dipped 46.4% to $1.1201.
    • Fast Radius, Inc. (NASDAQ:FSRD) shares fell 35.6% to $0.1350 on continued volatility after the company recently established a timeline for a Chapter 11 sale process. The company’s stock jumped 106% on Wednesday.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) declined 34.4% to $2.82.
    • Lightning eMotors, Inc. (NYSE:ZEV) dropped 33.3% to $0.7398.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) dipped 33% to $1.20.
    • Tenaya Therapeutics, Inc. (NASDAQ:TNYA) fell 25.9% to $2.3650 after the company announced pricing of a public offering of 22,613,307 shares of common stock at a price of $2.60 per share.
    • Editas Medicine, Inc. (NASDAQ:EDIT) dropped 19.3% to $9.88 after the company announced clinical data from the Phase 1/2 BRILLIANCE trial of EDIT-101.
    • DZS Inc. (NASDAQ:DZSI) fell 17.4% to $11.26 after the company announced pricing of a roughly $28.8 million public offering of 3,377,315 shares at a price of $11.50 per share
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 16.4% to $0.1171 after jumping around 12% on Wednesday.
    • Kinnate Biopharma Inc. (NASDAQ:KNTE) dropped 16.1% to $8.11. Stifel downgraded Kinnate Biopharma from Buy to Hold and lowered the price target from $35 to $11.
    • BrightView Holdings, Inc. (NYSE:BV) fell 16% to $7.55 following weak quarterly results.
    • BT Brands, Inc. (NASDAQ:BTBD) declined 14.4% to $1.72. BT Brands recently posted Q3 loss of $0.03 per share.
    • Bionomics Limited (NASDAQ:BNOX) fell 13.1% to $7.37 after the company reported pricing of underwritten offering of 641,026 American Depositary Shares in the U.S. at a price of $7.80 per ADS.
    • Audacy, Inc. (NYSE:AUD) dipped 12.8% to $0.3302.
    • Tattooed Chef, Inc. (NASDAQ:TTCF) dipped 12.7% to $2.3927. Tattooed Chef recently reported Q3 EPS and sales results were down year over year.
    • Dunxin Financial Holdings Limited (NYSE:DXF) dropped 12.3% to $0.2066.
    • Vaccitech plc (NASDAQ:VACC) fell 10.5% to $2.1563. Vaccitech recently posted Q3 EPS of $0.22.
    • Ormat Technologies, Inc. (NYSE:ORA) fell 9.6% to $90.40. Ormat reported pricing of upsized public offering of 3.75 million shares of common stock on behalf of stockholder ORIX Corporation at a price of $90 per share.
    • EZCORP, Inc. (NASDAQ:EZPW) fell 8.1% to $8.99 after the company reported Q4 results.
    • SenesTech, Inc. (NASDAQ:SNES) shares fell 6.2% to $3.05. SenesTech reported pricing of $5 million public offering.
    Get the next $ARDX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARDX
    $AUD
    $BBWI
    $BNOX

    CompanyDatePrice TargetRatingAnalyst
    Fossil Group Inc.
    $FOSL
    2/19/2026$7.00Outperform
    Northland Capital
    Cisco Systems Inc.
    $CSCO
    2/18/2026Buy → Hold
    Erste Group
    Bath & Body Works Inc.
    $BBWI
    2/17/2026$25.00Buy → Neutral
    Citigroup
    Ormat Technologies Inc.
    $ORA
    2/13/2026$130.00Buy → Hold
    Jefferies
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    CytomX Therapeutics Inc.
    $CTMX
    1/20/2026$10.00Buy
    Guggenheim
    Macy's Inc
    $M
    1/14/2026$27.00Buy
    Jefferies
    Bath & Body Works Inc.
    $BBWI
    1/14/2026$24.00Hold
    Jefferies
    More analyst ratings

    $ARDX
    $AUD
    $BBWI
    $BNOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Tillett Gary sold $255,000 worth of Class A Non-Voting Common Stock (10,000 units at $25.50), decreasing direct ownership by 7% to 133,483 units (SEC Form 4)

    4/A - EZCORP INC (0000876523) (Issuer)

    2/25/26 9:28:48 AM ET
    $EZPW
    Other Specialty Stores
    Consumer Discretionary

    Director Tillett Gary sold $255,000 worth of Class A Non-Voting Common Stock (10,000 units at $25.50), decreasing direct ownership by 7% to 133,483 units (SEC Form 4)

    4 - EZCORP INC (0000876523) (Issuer)

    2/25/26 9:20:48 AM ET
    $EZPW
    Other Specialty Stores
    Consumer Discretionary

    SVP & Chief Acctg Officer Wong Maria Victoria sold $169,395 worth of shares (2,179 units at $77.74), decreasing direct ownership by 7% to 28,807 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/24/26 6:25:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $ARDX
    $AUD
    $BBWI
    $BNOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    World Mobile Group Ltd Converts Payable Notes Into Equity, Acquiring Approximately 18.5% of Cuentas Inc. and Deepening a High-Growth Strategic Alliance

    Miami Beach, FL and London, UK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Cuentas Inc. (OTCQB:CUEN) and World Mobile Group Ltd today announced a transformative equity transaction in which World Mobile Group Ltd exercised its payable notes in exchange for 1,277,018 shares of common stock of Cuentas Inc., representing approximately 18.5% ownership of the Company. This strategic conversion signals a strong vote of confidence in Cuentas' platform and accelerates the companies' shared mission to build a next-generation mobile, blockchain, and media ecosystem. Cuentas Inc. and World Mobile Group Ltd. (UK) jointly own World Mobile LLC. World Mobile Group Ltd. owns and manages the rapidly expanding WMTx

    2/25/26 9:00:00 AM ET
    $CUEN
    Computer Software: Prepackaged Software
    Technology

    Splunk Report: Agentic AI Takes Center Stage in CISOs' Path to Digital Resilience

    Nearly all CISOs Report They Are Now Responsible for AI Governance and Risk Management, Cite the Growing Sophistication of Threat Actor Capabilities as Their Greatest RiskVast Majority Say AI Enables More Security Events to be Reviewed SAN JOSE, Calif., Feb. 24, 2026 /PRNewswire/ -- Cisco today announced the release of Splunk's annual report, The CISO Report: From Risk to Resilience in the AI Era, surveying 650 global Chief Information Security Officers (CISOs). The report highlights CISOs' rapidly expanding role, their strategic approach to AI adoption, and a steadfast commitment to human talent as they confront an increasingly complex landscape.

    2/24/26 8:00:00 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    IBN Announces Latest Episode of The TechMediaWire Podcast featuring David BenDavid, CEO of Rail Vision Ltd.

    AUSTIN, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The TechMediaWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The TechMediaWire Podcast delivers informative updates and exclusive interviews with executives operating in the tech industry. The TechMediaWire Podcast's latest episode features David BenDavid, CEO of Rail Vision Ltd. (NASDAQ:RVSN), an early commercialization stage technology company focused on transforming the railwa

    2/24/26 8:00:00 AM ET
    $RVSN
    Railroads
    Industrials

    $ARDX
    $AUD
    $BBWI
    $BNOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Fossil with a new price target

    Northland Capital initiated coverage of Fossil with a rating of Outperform and set a new price target of $7.00

    2/19/26 7:14:48 AM ET
    $FOSL
    Consumer Specialties
    Consumer Discretionary

    Cisco downgraded by Erste Group

    Erste Group downgraded Cisco from Buy to Hold

    2/18/26 9:41:39 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Bath & Body Works downgraded by Citigroup with a new price target

    Citigroup downgraded Bath & Body Works from Buy to Neutral and set a new price target of $25.00

    2/17/26 8:12:52 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ARDX
    $AUD
    $BBWI
    $BNOX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ARDX
    $AUD
    $BBWI
    $BNOX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDX
    $AUD
    $BBWI
    $BNOX
    SEC Filings

    View All

    SEC Form 144 filed by Ardelyx Inc.

    144 - ARDELYX, INC. (0001437402) (Subject)

    2/24/26 4:30:45 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Eason Technology Limited

    6-K - Eason Technology Ltd (0001499494) (Filer)

    2/24/26 4:05:12 PM ET
    $DXF
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Rail Vision Ltd.

    6-K - Rail Vision Ltd. (0001743905) (Filer)

    2/24/26 4:00:11 PM ET
    $RVSN
    Railroads
    Industrials

    $ARDX
    $AUD
    $BBWI
    $BNOX
    Financials

    Live finance-specific insights

    View All

    Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    IBSRELA revenue grew 73% in 2025 to $274.2 million and total revenues reached $407.3 million Patient-first XPHOZAH strategy preserved access and drove growth in total dispenses Development programs for new IBSRELA indication and next-generation NHE3 inhibitor launched Company is well capitalized to meet current business objectives Conference call scheduled for 4:30 PM Eastern Time WALTHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today reported financial results for the fourth quarter and full year

    2/19/26 4:01:00 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bath & Body Works to Report Fourth Quarter and Fiscal 2025 Results on March 4, 2026

    COLUMBUS, Ohio, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) announced today that it plans to report its fourth quarter and fiscal 2025 financial results before market open on Wednesday, March 4, 2026. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which Daniel Heaf, chief executive officer, and Eva Boratto, chief financial officer, will discuss the company's results and provide a business update. Supplemental materials will be posted approximately 90 minutes prior to the start of the conference call on the events and presentations page in the Investors section of the company's website at bbwinc.com. Investors and a

    2/18/26 8:30:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    CISCO REPORTS SECOND QUARTER EARNINGS

    SAN JOSE, Calif., Feb. 11, 2026 /PRNewswire/ --  News Summary: Double-digit top and bottom-line growth exceeding our guidance, with EPS growing faster than revenueRecord revenue of $15.3 billion, up 10% year over year; GAAP EPS of $0.80, up 31% year over year; and Non-GAAP EPS of $1.04, up 11% year over yearGAAP gross margin of 65.0% and Non-GAAP gross margin of 67.5%; GAAP operating margin of 24.6% and Non-GAAP operating margin of 34.6%, both above the high end of our guidance rangeAccelerating, double-digit growth in product orders across all geographies and robust growth ac

    2/11/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $ARDX
    $AUD
    $BBWI
    $BNOX
    Leadership Updates

    Live Leadership Updates

    View All

    FOSSIL GROUP, INC. APPOINTS SHANNON FREEZE AS CHIEF PEOPLE AND COMMUNICATIONS OFFICER

    RICHARDSON, Texas, Feb. 9, 2026 /PRNewswire/ -- Fossil Group, Inc. (NASDAQ:FOSL) ("Fossil" or the "Company") today announced the appointment of Shannon Freeze as Chief People and Communications Officer and a member of the Executive Leadership Team, reporting to CEO Franco Fogliato, effective February 23, 2026. In this role, she will oversee global communications and engagement, diversity and belonging, human resources, talent management, and total rewards. "We're thrilled to welcome Shannon to Fossil Group. As Chief People and Communications Officer and a member of the Executi

    2/9/26 9:00:00 AM ET
    $FOSL
    Consumer Specialties
    Consumer Discretionary

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

    SAN DIEGO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced a leadership transition designed to support the Company's next phase of growth and advancement toward late-stage development and key clinical and corporate milestones. Mani Mohindru, PhD, a member of Cardiff Oncology's Board of Directors since 2021 and a seasoned biotech executive, has been appointed interim Chief Executive Officer, effective immediately. Mark Erlander, PhD, Chief Executive Officer, and James Levine, Chief Financial Officer, have stepped down from their res

    1/27/26 7:00:00 AM ET
    $CRDF
    $CTMX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ARDX
    $AUD
    $BBWI
    $BNOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Ormat Technologies Inc.

    SC 13D/A - ORMAT TECHNOLOGIES, INC. (0001296445) (Subject)

    12/13/24 4:05:21 PM ET
    $ORA
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Kiora Pharmaceuticals Inc.

    SC 13G/A - KIORA PHARMACEUTICALS INC (0001372514) (Subject)

    11/14/24 7:17:24 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care